# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Edema

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 238 results.
Molecular Mechanisms of Malignant Cerebral Edema After LHI
Status: Recruiting
Last Changed: Mar 03, 2020
First Received: Oct 11, 2018
Disease(s): Cerebral Edema
Intervention(s): Treatments to reduce intracranial pressure
Locations: Xuanwu Hospital of Capital Medical University, Beijing, China
Comparison of VA Guided Versus OCT Guided TER Using Aflibercept for Diabetic Macular Edema (AVOCT Study)
Status: Recruiting
Last Changed: Mar 26, 2020
First Received: Jan 09, 2018
Disease(s): Diabetic Macular Edema
Intervention(s): OCT guided treatment arm, VA guided treatment arm
Locations: Inselspital Bern, Department of Ophthalmology, Bern, Switzerland
Efficacy and Tolerance of Hypertonic Sodium Chloride (NaCl 5%) Eye Drops Without Preservatives in Corneal Edema
Status: Not yet recruiting
Last Changed: Oct 08, 2020
First Received: Oct 14, 2019
Disease(s): Corneal Edema
Intervention(s): hypertonic Sodium chloride (NaCl 5%) eye drops solution in single-dose
Locations: Hospital Universitario Príncipe de Asturias, Alcalá De Henares, Spain
Subchondroplasty for Treatment of Bone Marrow Edema in the Foot and Ankle
Status: Not yet recruiting
Last Changed: May 15, 2019
First Received: Apr 19, 2019
Disease(s): Bone Marrow Edema
Intervention(s): Subchondroplasty
A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema.
Status: Recruiting
Last Changed: Oct 01, 2018
First Received: Oct 01, 2018
Disease(s): Diabetic Macular Edema
Intervention(s): Diode 577 nm subthreshold micropulse laser, Standard threshold laser (532 nm laser)
Locations: Belfast Health & Social Care Trust, Belfast, United Kingdom
Bradford Royal Infirmary, Bradford, United Kingdom
Bristol Eye Hospital, Bristol, United Kingdom
Frimley Park Hospital, Frimley, United Kingdom
Hull and East Yorkshire Hospital, Hull, United Kingdom
... and 10 other locations.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2798745 in Subjects With Diabetic Macular Edema (DME)
Status: Recruiting
Last Changed: Oct 27, 2020
First Received: Mar 03, 2020
Disease(s): Macular Edema
Intervention(s): GSK2798745
Locations: GSK Investigational Site, Adelaide, South Australia, Australia
Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema
Status: Recruiting
Last Changed: Nov 03, 2020
First Received: Sep 03, 2020
Disease(s): Diabetic Macular Edema
Intervention(s): UBX1325
Locations: Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
Salehi Retina Institute, Huntington Beach, California, United States
MedEye Associates, Miami, Florida, United States
Houston Eye Associates, Houston, Texas, United States
Medical Center Ophthalmology Associates, San Antonio, Texas, United States
... and 1 other locations.
Changes in Optical Coherence Tomography Leakage Mapping in Diabetic Macular Edema After Conbercept Treatment
Status: Not yet recruiting
Last Changed: Feb 05, 2020
First Received: Feb 05, 2020
Disease(s): Diabetic Macular Edema
Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab
Status: Recruiting
Last Changed: Jun 04, 2019
First Received: Jun 04, 2019
Disease(s): Diabetic Macular Edema
Intervention(s): Ranibizumab
Locations: Kunbei Lai, Guangzhou, Guangdong, China
A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
Status: Recruiting
Last Changed: Nov 10, 2020
First Received: Jul 14, 2020
Disease(s): Diabetic Macular Edema
Intervention(s): Iluvien 0.19 MG Drug Implant, Aflibercept
Locations: Investigative Site, Phoenix, Arizona, United States
Investigative Site, Glendale, California, United States
Investigative Site, Colorado Springs, Colorado, United States
Investigative Site, Clearwater, Florida, United States
Investigative Site, Lemont, Illinois, United States
... and 11 other locations.